Researchers are developing a greater understanding of Parkinson’s disease, the fastest growing neurodegenerative disease ...

More than 1 million Americans live with tremors, slowed movement and speech changes caused by Parkinson's disease—a ...

Diego Guarin, a University of Florida researcher exploring how artificial intelligence can transform the way Parkinson’s ...

AC Immune shares were higher after the pharmaceutical company reported positive interim results from a Phase 2 trial for a Parkinson's disease treatment. Shares were up 13% to $3.14 in Thursday ...

Van Andel Institute and Cure Parkinson’s have renewed a funding agreement to support the International Linked Clinical Trials Program, the world’s largest drug repurposing clinical trial initiative ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, led by researchers at UCL and Newcastle University. The £26 million project ...

Van Andel Institute and Cure Parkinson's have renewed a funding agreement to support the International Linked Clinical Trials ...

The number of people living with Parkinson's disease globally has doubled in the past 25 years. Yet the treatment and monitoring of the neurological disease seems many decades behind. Clinicians ...

For years, researchers have watched the tiny power plants inside brain cells falter in Parkinson’s disease and wondered what came first. Did those damaged mitochondria trigger the illness, or did they ...